Clinical trial
Clinical Trial of Gabapentin to Decrease Postoperative Delirium and Pain
NCT00221338 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00221338 |
|---|---|
| Title | Clinical Trial of Gabapentin to Decrease Postoperative Delirium and Pain |
| Official title | Clinical Trial of Gabapentin to Decrease Postoperative Delirium and Pain in Surgical Patients |
| Lead sponsor | University of California, San Francisco, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Postoperative Delirium, Postoperative Pain, Opioid Use, Hospital Length of Stay |
| Intervention type | Drug |
| Interventions | Gabapentin |
| Enrollment | 750 |
| Start date | Jan 1, 2006 |
| Primary completion | Jan 1, 2014 |
| Completion | Jul 1, 2014 |
| First posted | Sep 22, 2005 |
| Last update posted | Sep 10, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: